Ticker Scorecard - INO Basics Company: Inovio Pharmaceuticals, Inc. IPO Date: August 23, 1999 Sector: Healthcare Industry: Biotech Market Cap: $80.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.61% Avg Daily Range (30 D): $0.07 | 3.46% Avg Daily Range (90 D): $0.10 | 3.04% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): .91M Avg Daily Volume (90 D): .77M Trade Size Avg Trade Size (Sh.): 21 Avg Trade Size (Sh.) (30 D): 175 Avg Trade Size (Sh.) (90 D): 160 Institutional Trades Total Inst.Trades: 3,981 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $1.25M Avg Inst. Trade (90 D): $.88M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $2.59M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $.51M Avg Closing Volume: 44K     News May 22, 2024 @ 1:45 PM Better Buy: Inovio Pharmaceuticals vs. Novavax Source: newsfeedback@fool.com (Prosper Junior Bakiny) May 14, 2024 @ 6:37 PM DNA Medicine Focused INOVIO Pharma Efficiencies Im... Source: Vandana Singh May 14, 2024 @ 1:45 AM Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call... Source: newsfeedback@fool.com (Motley Fool Transcribing) May 9, 2024 @ 9:35 PM Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue... Source: Zacks Equity Research May 5, 2024 @ 12:54 PM This Under-the-Radar Stock Is Up by 96% This Year:... Source: newsfeedback@fool.com (Prosper Junior Bakiny) Financials   TTM Q2 2024 Q1 2024 Basic EPS $-8.28 $-1.19 $-1.31 Diluted EPS $-8.28 $-1.19 $-1.31 Revenue $ .59M $ .1M $ M Gross Profit $ $ $ Net Income / Loss $ -121.64M $ -32.24M $ -30.47M Operating Income / Loss $ -127.63M $ -33.2M $ -31.48M Cost of Revenue $ $ $ Net Cash Flow $ -18.32M $ 14.79M $ 5.29M PE Ratio     Splits Jan 25, 2024:   12:1 Jun 09, 2014:   4:1 Jun 06, 2014:   4:1 Sep 13, 2004:   4:1